(NASDAQ: SION) Sionna Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 22.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.
Sionna Therapeutics's earnings in 2025 is N/A.On average, 2 Wall Street analysts forecast SION's earnings for 2025 to be -$137,447,487, with the lowest SION earnings forecast at -$168,996,429, and the highest SION earnings forecast at -$105,898,546.
In 2026, SION is forecast to generate -$138,771,219 in earnings, with the lowest earnings forecast at -$171,202,649 and the highest earnings forecast at -$106,339,790.